SciVision Biotech (1786.TW) Stock Price

SciVision Biotech Price

TWSE·CLOSED
39.65
​
Market closed

Over the last 18 years SciVision Biotech grew revenue by 26.5% annually, reaching 886.62 M TWD. Earnings per share have grown at 6.1% per year over the last 14 years. For SciVision Biotech, the net margin of 18.3% is down versus 20.1% a few years ago. At today's price the dividend yield works out to roughly 8.17%. The payout ratio is around 146% of earnings. The dividend has grown at 18.0% per year over the past 11 years. The consensus 12-month price target for SciVision Biotech is 148.92 TWD, about 275.6% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

SciVision Biotech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SciVision Biotech business model & stock analysis

SciVision Biotech Inc, based in Kaohsiung, Taiwan, specializes in the research, development, and production of hyaluronic acid medical products. The company offers subcutaneous fillers for plastic surgery, joint cavity injections for orthopedics, and hyaluronic acid raw materials. It also provides DNA identification, detection, sequencing, and related applications, alongside care products and food manufacturing. SciVision Biotech operates globally across the Americas, Europe, Asia, the Middle East, and Africa.

Frequently asked questions about SciVision Biotech

Analysts currently set an average price target of 148.92 TWD for the SciVision Biotech stock (median: 148.92 TWD), implying +275.6 % versus the latest price. The consensus is based on 8 analyst ratings.

7 analysts currently rate the SciVision Biotech stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the SciVision Biotech share trades at 1.09 EUR (39.65 TWD).

The SciVision Biotech share (1786.TW) is listed on 1 stock exchanges, including: TWSE (Taiwan) (1786.TW).

The revenue cannot currently be calculated for SciVision Biotech.

The profit cannot currently be calculated for SciVision Biotech.

The P/E ratio cannot be calculated for SciVision Biotech at the moment.

The P/S cannot be calculated for SciVision Biotech currently.

The Eulerpool Quality Score for SciVision Biotech is 5/10.

The ISIN of SciVision Biotech is TW0001786002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of SciVision Biotech is 1786.TW. The ticker symbol is used to trade SciVision Biotech shares on the stock exchange.

Fair ValueTerminal
40.84 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Dec 29, 2010
ISIN
TW0001786002
Cusip
Y7557V106
Market capitalization
3.05 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
9.72
P/B Ratio
1.54
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.58 %
Dividend
Dividend yield
8.17 %
Payout Ratio
146.07 %
Dividend growth Ø5Y
27.54 %
Dividend payments per year
1
Dividend paid since
8 years
Dividend not reduced since
4 years
Dividend increased since
4 years
Dividend withholding tax
21.00 %
Last updated Oct 20, 2026, 1:15 AM

SciVision Biotech Peer Group

SciVision Biotech Ticker

TWSE · 1786.TW

SciVision Biotech FIGI

1786:TT (Taiwan Stock Exchange) · BBG001C873X6